324 related articles for article (PubMed ID: 23976977)
1. Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis.
Ortega-Prieto AM; Sheldon J; Grande-Pérez A; Tejero H; Gregori J; Quer J; Esteban JI; Domingo E; Perales C
PLoS One; 2013; 8(8):e71039. PubMed ID: 23976977
[TBL] [Abstract][Full Text] [Related]
2. Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus.
Nyström K; Wanrooij PH; Waldenström J; Adamek L; Brunet S; Said J; Nilsson S; Wind-Rotolo M; Hellstrand K; Norder H; Tang KW; Lagging M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045981
[TBL] [Abstract][Full Text] [Related]
3. Resistance of high fitness hepatitis C virus to lethal mutagenesis.
Gallego I; Gregori J; Soria ME; García-Crespo C; García-Álvarez M; Gómez-González A; Valiergue R; Gómez J; Esteban JI; Quer J; Domingo E; Perales C
Virology; 2018 Oct; 523():100-109. PubMed ID: 30107298
[TBL] [Abstract][Full Text] [Related]
4. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
Perales C; Agudo R; Domingo E
PLoS One; 2009; 4(5):e5554. PubMed ID: 19436746
[TBL] [Abstract][Full Text] [Related]
5. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
[TBL] [Abstract][Full Text] [Related]
6. Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
Bassi MR; Sempere RN; Meyn P; Polacek C; Arias A
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914957
[TBL] [Abstract][Full Text] [Related]
7. Rare haplotype load as marker for lethal mutagenesis.
Gregori J; Soria ME; Gallego I; Guerrero-Murillo M; Esteban JI; Quer J; Perales C; Domingo E
PLoS One; 2018; 13(10):e0204877. PubMed ID: 30281674
[TBL] [Abstract][Full Text] [Related]
8. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes.
Lanford RE; Chavez D; Guerra B; Lau JY; Hong Z; Brasky KM; Beames B
J Virol; 2001 Sep; 75(17):8074-81. PubMed ID: 11483752
[TBL] [Abstract][Full Text] [Related]
9. Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity.
Brochot E; Duverlie G; Castelain S; Morel V; Wychowski C; Dubuisson J; François C
Antivir Ther; 2007; 12(5):805-13. PubMed ID: 17713164
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
[TBL] [Abstract][Full Text] [Related]
11. Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space.
Perales C; Henry M; Domingo E; Wain-Hobson S; Vartanian JP
J Virol; 2011 Dec; 85(23):12227-40. PubMed ID: 21917974
[TBL] [Abstract][Full Text] [Related]
12. Selection of hepatitis C virus resistant to ribavirin.
Feigelstock DA; Mihalik KB; Feinstone SM
Virol J; 2011 Aug; 8():402. PubMed ID: 21843317
[TBL] [Abstract][Full Text] [Related]
13. Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus.
Perales C; Agudo R; Manrubia SC; Domingo E
J Mol Biol; 2011 Mar; 407(1):60-78. PubMed ID: 21256131
[TBL] [Abstract][Full Text] [Related]
14. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Perales C; Agudo R; Tejero H; Manrubia SC; Domingo E
PLoS Pathog; 2009 Nov; 5(11):e1000658. PubMed ID: 19911056
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy.
Hofmann WP; Polta A; Herrmann E; Mihm U; Kronenberger B; Sonntag T; Lohmann V; Schönberger B; Zeuzem S; Sarrazin C
Gastroenterology; 2007 Mar; 132(3):921-30. PubMed ID: 17383421
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model.
Galli A; Mens H; Gottwein JM; Gerstoft J; Bukh J
Sci Rep; 2018 Mar; 8(1):4619. PubMed ID: 29545599
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
Kanda T; Yokosuka O; Imazeki F; Tanaka M; Shino Y; Shimada H; Tomonaga T; Nomura F; Nagao K; Ochiai T; Saisho H
J Viral Hepat; 2004 Nov; 11(6):479-87. PubMed ID: 15500548
[TBL] [Abstract][Full Text] [Related]
18. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis.
Airaksinen A; Pariente N; Menéndez-Arias L; Domingo E
Virology; 2003 Jul; 311(2):339-49. PubMed ID: 12842623
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
20. Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin.
Mori K; Hiraoka O; Ikeda M; Ariumi Y; Hiramoto A; Wataya Y; Kato N
Hepatology; 2013 Oct; 58(4):1236-44. PubMed ID: 23532970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
